Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
17.11
-7.57 (-30.67%)
At close: Oct 31, 2024, 4:00 PM
17.13
+0.02 (0.12%)
After-hours: Oct 31, 2024, 4:21 PM EDT

Anika Therapeutics Revenue

Anika Therapeutics had revenue of $38.75M in the quarter ending September 30, 2024, a decrease of -6.54%. This brings the company's revenue in the last twelve months to $164.17M, up 0.52% year-over-year. In the year 2023, Anika Therapeutics had annual revenue of $166.66M with 6.67% growth.

Revenue (ttm)
$164.17M
Revenue Growth
+0.52%
P/S Ratio
1.54
Revenue / Employee
$459,854
Employees
357
Market Cap
253.17M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023166.66M10.43M6.67%
Dec 31, 2022156.24M8.44M5.71%
Dec 31, 2021147.79M17.34M13.29%
Dec 31, 2020130.46M15.85M13.83%
Dec 31, 2019114.61M9.06M8.58%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Enhabit 1.04B
DocGo 742.84M
ZimVie 453.38M
Amylyx Pharmaceuticals 298.76M
Voyager Therapeutics 143.77M
MaxCyte 45.44M
Alpha Teknova 34.94M
ClearPoint Neuro 28.07M
Revenue Rankings